<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02863757</url>
  </required_header>
  <id_info>
    <org_study_id>H&amp;H_NAFLD/CHB</org_study_id>
    <nct_id>NCT02863757</nct_id>
  </id_info>
  <brief_title>Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease</brief_title>
  <official_title>Disease Progression and Clinical Outcomes in Chronic Hepatitis B (CHB) Patients With Comorbid Nonalcoholic Fatty Liver Disease (NAFLD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Humanity and Health Research Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Humanity and Health Research Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the disease progression in CHB/NAFLD compared with
      CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma
      (HCC).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with liver cirrhosis, hepatic encephalopathy, esophageal varices, ascites and hepatocellular carcinoma</measure>
    <time_frame>Up to 20 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with hypertension, obesity, diabetes mellitus, hyperlipidaemia</measure>
    <time_frame>Up to 20 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with liver transplantation and liver-related death</measure>
    <time_frame>Up to 20 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnosis time of liver cirrhosis, hepatic encephalopathy, esophageal varices, ascites and hepatocellular carcinoma from baseline</measure>
    <time_frame>Up to 20 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence time of liver transplantation and liver-related death from baseline</measure>
    <time_frame>Up to 20 years</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Chronic Hepatitis B</condition>
  <condition>Nonalcoholic Fatty Liver Disease</condition>
  <arm_group>
    <arm_group_label>CHB Group</arm_group_label>
    <description>Patients with chronic hepatitis B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHB/NAFLD Group</arm_group_label>
    <description>Patients with chronic hepatitis B and comorbid nonalcoholic fatty liver disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NAFLD Group</arm_group_label>
    <description>Patients with nonalcoholic fatty liver disease</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Hosptials and primary care clinics
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Liver biopsy proved CHB and/or NAFLD at baseline;

          -  Chinese

          -  Follow-up duration&gt;12 months

        Exclusion Criteria:

          -  Other liver diseases;

          -  Secondary causes of hepatic steatosis;

          -  Alcohol abuse;

          -  Liver cirrhosis, cirrhosis related complications or HCC at baseline;

          -  Malignancy;

          -  History of liver transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>George Lau, MD</last_name>
    <phone>+852 2861 3777</phone>
    <email>gkklau@netvigator.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Humanity and Health GI and Liver Centre</name>
      <address>
        <city>Hong Kong</city>
        <state>Hong Kong</state>
        <zip>00852</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George KK Lau, MD</last_name>
      <phone>(852)28613777</phone>
      <email>gkklau@netvigator.com</email>
    </contact>
    <investigator>
      <last_name>George KK Lau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2016</study_first_submitted>
  <study_first_submitted_qc>August 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>May 8, 2017</last_update_submitted>
  <last_update_submitted_qc>May 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis, Chronic</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Hepatitis B, Chronic</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

